But on the other hand
Prof. Ehud Grossman of Tel Aviv University has published an overview of the hypertension impact of over-the-counter medicines. Some physicians are also unaware of the risks of such medication and that harmful effects may outweigh the benefits.
US & Israel med schools joint cancer research
Over the coming months, Bar-Ilan University's Faculty of Medicine in the Galilee and University of Miami's Miller School of Medicine will explore the joint development of a cancer centre which will integrate scientific research.
Good results for ovarian cancer drug
Israel’s Biocancell Therapeutics announced that phase 1/II(a) trials have proved BC-819 to be safe and effective in treating ovarian cancer.
Not one, not two, but three brain disease treatments
US biotech NeuroPhage Pharmaceuticals has raised finance to develop brain disease treatment products based on the discovery of Tel Aviv University professor Beka Solomon. Prof Solomon's discovery is already being used by Elan Corporation (USA) and Israel's NasVax to develop treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's.
Dolphin therapy – speechless success
(Thanks to NoCamels) 21 year-old Morad Azva had been mute since an attack in 2007. After medical treatments showed no progress, he was sent to the Dolphin Reef in Eilat for "dolphin therapy". There, he began to communicate through the interaction with dolphins.
A platform to analyse cancer
(thanks to NoCamels) IBM Haifa has been developing its Clinical Genomics platform since 2007. It has announced that it can now deliver personal treatment recommendations based on an automated interpretation of pathology guidelines, as well as cases documented in hospital information systems.
Fighting Sceptic shock
Sepsis is the body’s final response to infection and is responsible for over 200,000 deaths in the US every year. The non-invasive haemo-dynamic monitoring systems from Israel’s Cheetah Medical are used in the management of sepsis and are at the centre of a clinical study into the condition.
Record number of bone marrow transplants in 2011
In 2011, 183 leukaemia patients received bone marrow transplant donations in Israel. Donors to Ezer Mizion - an Israeli health support organization - provided the bone marrow for the ill patients.
Detecting early stage lung cancer
Israeli biotech BioView Ltd has announced that it has signed a cooperation agreement with OncoMDx of California, to develop a non-invasive diagnostic test for the early detection of non-small cell lung cancer (NSCLC). NSCLC accounts for 85% of all lung cancer cases.
New compound protects against ALS
Israeli researchers have identified a chemical compound that may lead to prolonged lifespans for patients with Amytotrophic lateral sclerosis (ALS) and other neuro-degenerative diseases. The compound can induce an increased production of the enzyme telomerase which slows the progression of ALS, also known as Lou Gehrig’s disease.